Menu
Washingtoner
  • Home
  • Health
  • Technology
  • Artificial Intelligence
  • Financial
  • Non-profit
  • Business
  • Concealed Carry
  • Music
Washingtoner

Seagen Statement on Outcome of Daiichi Sankyo Arbitration
Washingtoner/10182820

Trending...
  • Tacoma: Street Closures Projected to Start August 25 for Residential Street Restoration Program Maintenance Work
  • Spokane: City Council Approves Mayor's Orders for Declaration of Emergency
  • Tallahassee Million-Dollar Home Sales Rise in 2026 as Median Selling Time More Than Doubles
BOTHELL, Wash.--(BUSINESS WIRE)--Seagen Inc. (Nasdaq: SGEN) today issued a statement regarding the outcome of the arbitration with Daiichi Sankyo Co. Ltd. ("Daiichi Sankyo") relating to the parties' 2008 collaboration agreement for the use of Seagen's antibody-drug conjugate (ADC) technology. The arbitrator ruled in favor of Daiichi Sankyo, citing statute of limitations and disagreement with Seagen on the interpretation of the contract.

"While we are disappointed with the arbitration decision, it was important for us to pursue this legal action," said Roger Dansey, M.D., interim Chief Executive Officer and Chief Medical Officer, Seagen. "This does not impact our existing business. Looking forward, we are well-positioned to drive continued innovation and growth with four commercial products and a deep and diverse pipeline of promising programs. Seagen remains focused on developing innovative medicines that make a meaningful difference in the lives of cancer patients."

More on Washingtoner
  • RAS AP Consulting Spotlights Managed AP Governance™ at Esker All Access
  • Kent Youth And Family Services Names Omar Malik As New Executive Director
  • Spokane: SPD Seek Assistance in Locating Missing Vulnerable Adult Female
  • ANSI BSR Upholds Appeal of AFDE Member Andrew Sulner, MSFS, JD, finding the AAFS Academy Standards Board (ASB) Violated ANSI Essential Requirements
  • Haven Treatment Center Surprises Team Member with New Bicycle After Transportation Challenge

About Seagen

Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people's lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union. For more information on the company's marketed products and robust pipeline, visit www.seagen.com and follow @SeagenGlobal on Twitter.

Forward Looking Statements

Certain of the statements made in this press release are forward looking, such as those, among others, relating to Seagen's continued innovation and growth, as well as its pipeline. Actual results or developments may differ materially from those projected or implied in these forward-looking statements. Factors that may cause such a difference include, without limitation, the risk that the company's financial results may not be as expected and the difficulty and uncertainty of pharmaceutical product development. More information about the risks and uncertainties faced by the company is contained under the caption "Risk Factors" included in Seagen's Quarterly Report on Form 10-Q for the quarter ended June 30, 2022, filed with the Securities and Exchange Commission. Seagen disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise except as required by applicable law.

More on Washingtoner
  • Kentucky's Plane Crash Data Lands Far from the State's Busiest Airports
  • DBF Viewer 2000 v9.29 Now Supports Batch Field Renaming Across Multiple Files
  • StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
  • Continuous You Foundation Opens Applications For A 100-year Artist Grant
  • Netberg Announces the Aurora X2 Switch Series, Built on Xsight Labs' Programmable X2 Silicon

Contacts

For Media

David Caouette
(310) 430-3476
dcaouette@seagen.com

For Investors
Peggy Pinkston
(425) 527-4160
ppinkston@seagen.com
Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • L2 Aviation and Gotonomi Extend UAV Connectivity Beyond Cellular Reach
  • Tacoma: Hylebos Bridge Closed Today for Maintenance Work
  • Democratic Candidate Daria Ilgen Announces Taxpayer Accountability Standard for New Taxes
  • Re:InvestorHub Launches the First AI-Powered Operating System Built for Real Estate Investors
  • Nadi Plumbing Leads Charlotte in Private Fire Hydrant Services, Eyes Regional Expansion
  • FindCostSeg Launches Nationwide Directory for Cost Segregation Providers
  • Master Of Science, Juggernaut Of The Screen: Landon Brittain Emerges As Hollywood's Most Unlikely Leading Man
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
  • ExtraCarry Adds Pocket-Carry Holder for POM Pepper Spray
  • City of Spokane Receives $1 Million in Wildfire Housing Assistance
  • New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
  • ExtraCarry Adds .327 Federal Magnum to Speed Strip Pocket Holder Lineup
  • Tacoma: Street Closures Projected to Start August 25 for Residential Street Restoration Program Maintenance Work
  • Food Journal Magazine Focuses Its Los Angeles Dining Coverage Across Three Editorial Verticals
  • Gravity Payments and Suno Software Partner to Simplify Payments for Independent Hearing Clinics
  • Where Do Missouri Plane Crashes Really Happen? Not Where You'd Think
  • Spokane: Female Arrested After Homeowners Caught Her on Property of Burned Home
  • SPD Detectives are Investigating a Suspicious Death in West Spokane
  • LCC Asia Pacific Sponsors CubeSatPlus 2026 at UNSW Sydney
  • Spokane: City Council Approves Mayor's Orders for Declaration of Emergency
_catLbl0 _catLbl1

Popular on Washingtoner

  • Heritage at South Brunswick Introduces New Ferndale Floorplan: The Largest Single-Family Home Design in the Community - 522
  • Spokane: SPD Arrest Level III Registered Sex Offender for Failure to Register - 328
  • Tacoma: Applications Now Being Accepted for three Positions on the Urban Design Board - 124
  • Omnitronics launches Ecosystem Health Dashboard to enable proactive monitoring across dispatch environments
  • Phinge Exposes Massive AI Security Risks, Claiming Its Patented Hardware-Verified Architecture Is The Only Safeguard Against Surveillance Capitalism
  • On the Boards: Proform Builds Announce New Construction in Alki, Seattle
  • Tacoma: Capital Ready: Preparing Businesses for Growth in Public Contracting Workshop on August 26, 2026
  • Premier Expands Presence with New Bellevue Flexible Workspace Location
  • $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
  • Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials

Similar on Washingtoner

  • RAS AP Consulting Spotlights Managed AP Governance™ at Esker All Access
  • ANSI BSR Upholds Appeal of AFDE Member Andrew Sulner, MSFS, JD, finding the AAFS Academy Standards Board (ASB) Violated ANSI Essential Requirements
  • StockResearch AI Initiates Coverage on Apple (AAPL) With New Report Examining Valuation, AI Strategy and Future Growth
  • Pete Verbica: America Needs Statesmanship and Common Sense — Not a Cult of Personality
  • When the Coroner's Report Isn't Enough: Colorado Families Turn to Private Autopsy for Closure
  • New Analysis Details Three Converging Forces in AI and Workforce Policy Behind a $37 Billion GDP Reduction
  • Popular AI planner Voiset launches version 2.0 and enters MENA at LEAP 2026 with full Arabic support
  • Black Dog Venture Partners and VC Fast Pitch to Host "San Francisco Investors and Innovators" Networking Event
  • Real Estate Syndication Attorney Tilden Moschetti Releases The Real Estate Private Equity Blueprint
  • 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute